<DOC>
	<DOCNO>NCT00417040</DOCNO>
	<brief_summary>This pilot clinical trial study well use internet collect symptom ability carry daily activity work patient enrol Cancer Leukemia Group B ( CALGB ) study . A study evaluate patient 's ability use clinic waiting room computer report symptom ability carry daily activity may help doctor understand patient 's use computer report symptom .</brief_summary>
	<brief_title>Collection Patient-Reported Symptoms Performance Status Via Internet</brief_title>
	<detailed_description>This study enrol participant diagnose breast cancer , lung cancer , colorectal cancer , leukemia multiple myeloma prostate cancer . PRIMARY OBJECTIVES : I . To assess feasibility collect symptom data directly patient clinic visit via waiting-area computer . II . To preliminarily assess level agreement patient clinician Common Terminology Criteria Adverse Events ( CTCAE ) symptom severity scoring , measure whether score converge clinician expose patient self-reports . OUTLINE : Patients register Symptom Tracking Reporting ( STAR ) database , obtain password , undergo STAR training , complete patient-STAR questionnaire see clinician ( baseline self-report ) day 1 course 2* chemotherapy . Patients remind complete online STAR questionnaire see clinician day 1 course 3 , 4 , 5 , 6* chemotherapy . Clinicians review patient report create assessment . Patients also complete patient feedback survey day 1 course 4* chemotherapy . Clinicians complete feedback survey study completion .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Enrolled clinical trial CALGB90401 , CALGB30607 , CALGB30704 , CALGB40601 , CALGB40603 , CALGB40502 , CALGB40503 , CALGB70604 , CALGB80405 PATIENT CHARACTERISTICS : Able read comprehend English language text Able see computer screen ( i.e. , visual impairment ) accompany visit someone read screen patient PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>